News
FDA to "review the latest data" on mifepristone. What could it mean for access to the abortion pill?
HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone," but experts say concerns ...
An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...
A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...
FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.
Pro-life movement faces challenges as abortions remain frequent after Dobbs, focusing on defunding Planned Parenthood, ...
Three years after the Dobbs decision, the legal challenges continue for activists on both sides of the abortion debate.
In the second phase of CATALYST, individuals who had abnormal cortisol suppression were offered the opportunity to take part in a randomized trial of mifepristone, a medication that reduces the ...
Plaintiffs argued the statute would indirectly ban abortion medications by threatening providers with disciplinary action for ...
A growing body of research demonstrating the safety and effectiveness of self-managed abortion with pills, coupled with the ...
In patients with hypercortisolism and inadequately controlled type 2 diabetes, mifepristone lowered HbA1c levels by about 1.5 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results